Patent · US Expired

Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for GvHD in allogeneic antitumor cell therapy

US8066989B2 · kind B2 · utility

6Cited by

5References

15Claims

0Family size

Assignee

Trion Pharma GmbH · DE

Inventors

Horst Lindhofer · Puchheim, DE
Shimon Slavin · Jerusalem, IL
Shoshana Morecki · Jerusalem, IL

Key dates

Filing date	Nov 30, 2004
Grant date	Nov 29, 2011
Priority date	—
Expiry date	Nov 26, 2025

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention refers to a method of treating tumor growth and metastasis in a mammal, the treating comprising administering allogeneic effector cells together with trifunctional bispecific or trispecific antibodies or a combination thereof having the following properties:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.